QQ客服 官方微博 反馈留言

	Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
	Li, Jin; Qin, Shukui; Xu, Jianming; Xiong, Jianping; Wu, Changping; Bai, Yuxian; Liu, Wei; Tong, Jiandong; Liu, Yunpeng; Xu, Ruihua
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2016
卷号	34期号:13
ISSN号	0732-183X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4285655
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Li, Jin,Qin, Shukui,Xu, Jianming,et al. Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction[J]. JOURNAL OF CLINICAL ONCOLOGY,2016,34(13).
APA	Li, Jin.,Qin, Shukui.,Xu, Jianming.,Xiong, Jianping.,Wu, Changping.,...&Yu, Hao.(2016).Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.JOURNAL OF CLINICAL ONCOLOGY,34(13).
MLA	Li, Jin,et al."Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction".JOURNAL OF CLINICAL ONCOLOGY 34.13(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。